Company Filing History:
33 out of 33 
11 out of 4,948 
1 out of 53 Years Active: 2001-2013
Areas of Expertise:
Title: David S F Young: A Trailblazer in Cancer Research and Innovation
Introduction: David S F Young, residing in Toronto, CA, stands as a prominent figure in the realm of cancer research and innovation. With an impressive portfolio of 44 patents, his work is characterized by the development of groundbreaking methodologies and treatments aimed at combating cancerous diseases. His latest patents delve into the intricate mechanisms of cytotoxicity mediation and the production of cancerous disease modifying antibodies.
Latest Patents: Among his notable inventions is a patent titled "Cytotoxicity mediation of cells evidencing surface expression of CD44." This inventive work specifically addresses the diagnosis and treatment of cancer, focusing on the mediation of cytotoxic responses in primary and metastatic human tumor cells. Utilizing isolated monoclonal antibodies and cancerous disease modifying antibodies (CDMAB), his research offers innovative approaches for initiating therapeutic responses in various tumor sites, particularly those originating from hepatocytes. Another significant patent, "Cancerous disease modifying antibodies," outlines a novel method for producing anti-cancer antibodies. This method uses cancer cell cytotoxicity as an endpoint, enabling the production of antibodies for both therapeutic and diagnostic purposes in cancer staging and treatment.
Career Highlights: David has made substantial contributions to the field through his work with esteemed organizations such as Arius Research, Inc. and Hoffmann-La Roche Inc. His innovative spirit and commitment to cancer research have led to the development of vital therapeutic tools that seek to improve patient outcomes in oncology.
Collaborations: Throughout his career, David has collaborated with notable figures in the industry, including Susan E Hahn and Helen P Findlay. These collaborations have enriched his research and fostered advancements in the development of cancer therapies.
Conclusion: David S F Young's contributions to cancer research through his impressive array of patents exemplify his dedication to advancing medical science and improving patient care. His innovative approaches and collaborative efforts continue to inspire progress in the fight against cancer, making him a pivotal figure in the field of oncology.